PATRICK R. O'NEIL
CIK 1564926 · EVP CLO & General Counsel · last filed 2026-03-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.31M
Companies
2
Total Filings
130
Lifetime Open-Market Net
-$35.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP CLO & General Counsel | 62,211 | $53.28 | $3.31M | -$30.73M | 83 | 2026-03-11 |
| IONIS PHARMACEUTICALS INC (ISIS) Delisted | SVP, Legal & General Counsel | 7,259 | — | — | -$5.16M | 29 | 2015-12-02 |
Recent Filings · Page 13 of 13
130 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-04-23 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$324.9K | EDGAR |
| 2013-04-15 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$29.3K | EDGAR |
| 2013-03-22 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$45.7K | EDGAR |
| 2013-03-04 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$53.4K | EDGAR |
| 2013-02-20 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | — | -$8.8K | EDGAR |
| 2013-02-14 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | −139 | -$43.5K | EDGAR |
| 2013-01-31 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | −300 | -$13.1K | EDGAR |
| 2013-01-17 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +300 | -$3.4K | EDGAR |
| 2013-01-04 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Sell (S) | −1,296 | -$13.9K | EDGAR |
| 2013-01-03 | IONIS PHARMACEUTICALS INC (ISIS) Delisted | Mixed | +431 | $3.8K | EDGAR |
Showing 121–130 of 130
Prev
Page 13 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.